CompoAtlas

WASO KOSHIRICE TINTED ACNE TREATMENT

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Acide 2-hydroxybenzoïque

Source : Acide salicylique

0.5 %

Non-medicinal ingredients

Phénoxyéthanol, Dioxyde de titane, Acide citrique, SD alcool 40-B, Citrate de sodium, Glycérine, Diméthicone, Extrait de pelures de Citrus depressa, Hydroxyde d'aluminium, Oxydes de fer, Éthylhexanoate de cétyle, Eau de fruit de Pyrus Malus (pomme), Eau, Hydroxyde de potassium, EDTA trisodium, Extrait de racine de Paeonia Suffruticosa, Dipropylène glycol, Extrait de riz hydrolysé, Polysilicone-2, Glycyrrhizate de dipotassium, Butylène glycol, Sesquiisostéarate de sorbitan, Extrait de racine de Paeonia albiflora, PEG-9 Polydiméthylsiloxy éthyl diméthicone, Hectorite de distéardimonium, Stéarate de PEG-150, Acide benzoïque, Alcool

PopulationAgeQuantity per servingFrequency
Femmesminimum: 18 yearsNot specifiedNot specified
Population not specifiedminimum: 12 years ; maximum: 17 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

For the treatment/management of acne.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Other names
KOSHIRICE TINTED ACNE TREATMENT, TINTED ACNE TREATMENT
Licence holder
Shiseido (Canada) Inc.
NPN or DIN-HM
80104737
Status
Active licence
Licence date
2 October 2020
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Source

Official Health Canada record, licence 80104737

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “WASO KOSHIRICE TINTED ACNE TREATMENT (Shiseido (Canada) Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80104737-waso-koshirice-tinted-acne-treatment, updated 2 October 2020.

Enter to analyse, Shift+Enter for a new line